ArticlebioRxiv : the preprint server for biology2023
Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancer.
Ralph E White et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.